ASH Clinical News ACN_5.2_digital

2018: A Record-Breaking Year for Hematologic Drug Approvals Your source for worldwide news and perspectives on hematology/oncology volume 05 | number 02 january 2019 annual meeting edition CONTENTS Written in Blood Ravulizumab: A New Option for Paroxysmal Nocturnal Hemoglobinuria Literature Scan Shortening Decitabine Treatment in Older Patients With AML On Location Ibrutinib Beats Standard Therapy in CLL On Location Luspatercept Promising in Beta Thalassemia and MDS Highlights from the 2018 ASH ANNUAL MEETING IMPROVING PROGNOSIS, TREATMENT, AND OUTCOMES FOR PATIENTS WITH BLOOD DISORDERS WORLDWIDE DEPARTMENTS 6 UP FRONT 7 CLINICAL NEWS 39 BACK OF THE BOOK The Society Pages: Recent Promotions and Transitions Latest & Greatest: New and Noteworthy Research Data Stream: Health-Care Facts & Figures